- Joined
- Nov 15, 2006
- Messages
- 4,782
Good post man, thanks for sharing. Yea, I have no idea except heresy about ralox having less effects on clotting vs Nolva. I have never read any studies showing it was better, though i've not taken a deep dive into it all in many years. I'll leave that to people like @Type-IIx , @Mike Arnold , et al. At this point, I don't use enough AAS to hassle much with any of it. I have always liked the idea of both depending on the context of how they are used....and of course which is better as it pertains to people at risk of clotting and other sides.I talked to a gentlemen who was a sales rep for Nolvadex and then Evista. I asked him what the main side effects were and he stated blood clots were always their main concern and that applied EQUALLY to both drugs. Often times the "lack of sides" with the new medication is more a case of lack of as much data than it is lack of sides. All one has to do is look at the newest class of antipsychotics and their claims of "lower risk of tardive dyskinesia" well no shit a side that takes YEARS and YEARS of use often times decades to manifest shows up less in your less than a decade old med? No shit sherlock. By the time the truth comes out, if it does at all, the original players are long gone.
TLDR: Treat clotting risk with ralox as you would with tamox.